Tehran Court Sentences Four Protesters to Death Amidst Severe Drug Shortages
The Tehran Revolutionary Court has sentenced four detainees from the December protests—Mohammad-Reza Majidi-Asl, Beta Hemmati, Behrouz Zamani-Nia, and Kourosh Zamani-Nia—to death, five years in prison, and confiscation of all assets. Another defendant, Amir Hemmati, received a prison term of five years and eight months. This judicial action coincides with a deepening healthcare crisis in Iran, where citizens report acute shortages of both essential and common medications. Despite government assurances regarding strategic reserves, patients face skyrocketing prices for critical drugs such as insulin and cancer treatments, with some prices increasing by over twenty-fold. Reports indicate that even basic medicines like Aspirin and Gelofen are scarce, forcing patients to delay treatment or endure severe financial hardship. The situation has drawn sharp criticism from affected individuals, who describe the lack of access to effective foreign-made drugs as a death sentence. The convergence of harsh political repression and deteriorating public health infrastructure highlights the multifaceted challenges facing the country, as documented by HRANA and citizen reports via Iran International.
Wire timeline
Tehran Court Sentences Four Protesters to Death Amidst Severe Drug Shortages
The Tehran Revolutionary Court has sentenced four detainees from the December protests—Mohammad-Reza Majidi-Asl, Beta Hemmati, Behrouz Zamani-Nia, and Kourosh Zamani-Nia—to death, five years in prison, and confiscation of all assets. Another defendant, Amir Hemmati, received a prison term of five years and eight months. This judicial action coincides with a deepening healthcare crisis in Iran, where citizens report acute shortages of both essential and common medications. Despite government assurances regarding strategic reserves, patients face skyrocketing prices for critical drugs such as insulin and cancer treatments, with some prices increasing by over twenty-fold. Reports indicate that even basic medicines like Aspirin and Gelofen are scarce, forcing patients to delay treatment or endure severe financial hardship. The situation has drawn sharp criticism from affected individuals, who describe the lack of access to effective foreign-made drugs as a death sentence. The convergence of harsh political repression and deteriorating public health infrastructure highlights the multifaceted challenges facing the country, as documented by HRANA and citizen reports via Iran International.
ایران اینترنشنال